They lower blood sugar and help you lose weight
Rising costs lead insurers to drop weight loss drug coverage, further increasing patient burden, American Journal of Managed Care (2024) FDA approves first generic of once-daily GLP-1 injection to lower blood sugar in patients with type 2 diabetes, Food & Drug Administration (2024) What is medical necessity
The dosing frequency for sublingual drops is typically once daily
[4] Ultimately, the choice of GLP-1 agonist should be a collaborative decision between the patient and their healthcare provider, taking into account individual factors, treatment goals, and potential risks and benefits
However, we recommend following a balanced, nutritious diet to maximize the benefits of the medication and support overall health
Abstract Glucagon-like peptide-1 (GLP-1) receptor is widely distributed in the digestive system, cardiovascular system, adipose tissue and central nervous system